| Schedule of Balance Sheets |
| | |
As of June 30, | |
| | |
2025 | | |
2024 | |
| Assets | |
| | |
| |
| Cash and cash equivalents | |
$ | 28,761 | | |
$ | - | |
| Deposits, prepayments and other current assets, net | |
| 156,511 | | |
| - | |
| Due from related parties | |
| 1,000 | | |
| - | |
| Due from Intercompany | |
| 4,789,591 | | |
| - | |
| Investments in subsidiaries | |
| 3,405,852 | | |
| 2,745,097 | |
| Total Assets | |
$ | 8,381,715 | | |
$ | 2,745,097 | |
| Liabilities | |
| | | |
| | |
| Due to related parties | |
$ | 338,203 | | |
$ | 8,579 | |
| Due to Intercompany | |
| 997,363 | | |
| - | |
| Convertible bonds | |
| 1,080,266 | | |
| - | |
| Other payables | |
| 612,138 | | |
| - | |
| Total Liabilities | |
$ | 3,027,970 | | |
$ | 8,579 | |
| Equity: | |
| | | |
| | |
| Class A Ordinary Shares ($0.0001 par value; 400,000,000 shares authorized; 11,250,000 and 10,000,000 shares issued and outstanding as of June 30, 2025 and 2024, respectively) | |
$ | 1,125 | | |
$ | 1,000 | |
Class B Ordinary Shares (($0.0001 par value; 100,000,000 shares authorized; 580,000 and nil issued and outstanding as of June 30, 2025 and 2024, respectively) | |
| 58 | | |
| - | |
| Subscription receivables | |
| - | | |
| - | |
| Additional paid-in capital | |
| 2,050,003 | | |
| - | |
| Retained earnings | |
| 3,336,442 | | |
| 2,903,189 | |
| Accumulated other comprehensive loss | |
| (33,883 | ) | |
| (167,671 | ) |
| Total Equity | |
$ | 5,353,745 | | |
$ | 2,736,518 | |
| Total Liabilities and Equity | |
$ | 8,381,715 | | |
$ | 2,745,097 | |
| * | The
shares and per share data are presented on a retroactive basis to reflect the stock split. |
|
| Schedule of Statements of Operations |
| | |
For the years ended
June 30, | |
| | |
2025 | | |
2024 | |
| General and administration expenses | |
$ | (82,138 | ) | |
$ | (4,597 | ) |
| Other income | |
| - | | |
| - | |
| Other expenses | |
| (21,844 | ) | |
| - | |
| Exchange gain | |
| 24,676 | | |
| - | |
| Income from equity-method investment | |
| 844,226 | | |
| 1,552,944 | |
| Net income | |
$ | 764,919 | | |
$ | 1,548,347 | |
|
| Schedule of Statements of Cash Flows |
| | |
For the years ended
June 30, | |
| | |
2025 | | |
2024 | |
| Cash flows from operating activities | |
| | |
| |
| Net income | |
$ | 764,919 | | |
$ | 1,548,347 | |
| Gain from equity-method investment | |
| (2,881,504 | ) | |
| (1,548,347 | ) |
| Cash flows from investing activities | |
| (661,755 | ) | |
| - | |
| Cash flows from financing activities | |
| 3,438,232 | | |
| - | |
| Effect of exchange rate changes | |
| 133,788 | | |
| - | |
| Net change in cash and cash equivalents | |
| 28,761 | | |
| - | |
| Cash and cash equivalents at beginning of the year | |
| - | | |
| - | |
| Cash and cash equivalents at end of the year | |
$ | 28,761 | | |
$ | - | |
|